Cover Image
市場調查報告書

痙攣性雙側麻痺:全球臨床實驗檢討

Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014

出版商 GlobalData 商品編碼 309954
出版日期 內容資訊 英文
訂單完成後即時交付
價格
Back to Top
痙攣性雙側麻痺:全球臨床實驗檢討 Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014
出版日期: 2014年07月31日 內容資訊: 英文
簡介

本報告提供痙攣性雙側麻痺相關的臨床研究最新趨勢分析,彙整疾病治療方法概要,及臨床實驗的主要國家──G7各國及E7(新興7國)的臨床實驗數及實驗對象採用狀況,Phase、階段別進展,有潛力的贊助商,各企業研究機關的研究進展,有潛力的藥劑比較等資訊。

目錄

簡介

  • 痙攣性雙側麻痺
  • 本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 亞太地區主要國家的臨床實驗數量
    • 歐洲主要國家的臨床實驗數量
    • 北美主要國家的臨床實驗數量
    • 中東及非洲主要國家的臨床實驗數量

G7各國臨床實驗數量:中樞神經系統臨床實驗數量上,痙攣性雙側麻痺臨床實驗數量所佔的比例

G7各國臨床實驗數量:Phase別

G7各國臨床實驗數量:各進展狀況

E7各國(新興7個國家)臨床實驗數量:中樞神經系統臨床實驗數量上,痙攣性雙側麻痺臨床實驗數量所佔的比例

E7各國(新興7個國家)臨床實驗數量:Phase別

Phase別臨床實驗數量

各進展狀況臨床實驗數量

試驗指標達成狀況別臨床實驗數量

一定期間所採用的實驗對象

  • 有代表性的研究機關·醫院臨床實驗概要
    • National Taiwan University Hospital
    • National Institute of Neurological Disorders and Stroke
    • Nanjing Hospital
    • Thammasat University
    • Ahvaz Jundishapur University of Medical Sciences
    • University of Heidelberg
    • Universita degli Studi di Modena e Reggio Emilia
    • Manipal University
    • Shriners Hospitals for Children

5個有代表性的臨床實驗簡介

附錄

圖表一覽

目錄
Product Code: GlobalData

GlobalData's clinical trial report, "Spastic Diplegia Cerebral Palsy Global Clinical Trials Review, H2, 2014" provides data on the Spastic Diplegia Cerebral Palsy clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Spastic Diplegia Cerebral Palsy. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Spastic Diplegia Cerebral Palsy. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Spastic Diplegia Cerebral Palsy
  • Report Guidance
  • Clinical Trials by Region
    • Clinical Trials and Average Enrollment by Country
      • Top Countries Contributing to Clinical Trials in Asia-Pacific
      • Top Countries Contributing to Clinical Trials in Europe
      • Top Countries Contributing to Clinical Trials in North America
      • Top Countries Contributing to Clinical Trials in Middle East and Africa
  • Clinical Trials by G7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
    • Clinical Trial Overview of Top Institutes / Government
      • National Taiwan University Hospital
      • Clinical Trial Overview of National Taiwan University Hospital
      • National Institute of Neurological Disorders and Stroke
      • Clinical Trial Overview of National Institute of Neurological Disorders and Stroke
      • Nanjing Hospital
      • Clinical Trial Overview of Nanjing Hospital
      • Thammasat University
      • Clinical Trial Overview of Thammasat University
      • Ahvaz Jundishapur University of Medical Sciences
      • Clinical Trial Overview of Ahvaz Jundishapur University of Medical Sciences
      • University of Heidelberg
      • Clinical Trial Overview of University of Heidelberg
      • Universita degli Studi di Modena e Reggio Emilia
      • Clinical Trial Overview of Universita degli Studi di Modena e Reggio Emilia
      • Manipal University
      • Clinical Trial Overview of Manipal University
      • Shriners Hospitals for Children
      • Clinical Trial Overview of Shriners Hospitals for Children
  • Five Key Clinical Profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, North America, Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Neurological Disorders and Stroke, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Nanjing Hospital, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Thammasat University, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Ahvaz Jundishapur University of Medical Sciences, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Heidelberg, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Universita degli Studi di Modena e Reggio Emilia, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Manipal University, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials Market, Global, Clinical Trials by Shriners Hospitals for Children, 2014*

List of Figures

  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Region (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Asia-Pacific, Top Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Europe, Top Countries (%), 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, G7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014*
  • Proportion of Spastic Diplegia Cerebral Palsy to Central Nervous System Clinical Trials, E7 Countries (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, E7 Countries, Clinical Trials by Phase, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Phase (%), 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics, Global, Clinical Trials by Trial Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, by End Point Status, 2014*
  • Spastic Diplegia Cerebral Palsy Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013
  • GlobalData Methodology
Back to Top